Nichol Miller

Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor

Kevin D. Freeman‐Cook, Robert L. Hoffman, Nichol Miller et al. · Cancer Cell · 2021 · 172 citations

Tumor Biology, Oncology, Cdk2/4/6 Inhibitor +10

Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function

Christine Jean, Xiao Lei Chen, Ju‐Ock Nam et al. · The Journal of Cell Biology · 2014 · 171 citations · Full text

Fak Inhibition, Cancer Biology, Tumor Biology +16

Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity

Mansi Arora, Justin Moser, Timothy E. Hoffman et al. · Cell · 2023 · 158 citations

Signal Transduction, Cdk2 Inhibition, Cell Division +6

Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate

Stefano Crosignani, Patrick Bingham, Pauline Bottemanne et al. · Journal of Medicinal Chemistry · 2017 · 134 citations · Full text

Knock-in Mutation Reveals an Essential Role for Focal Adhesion Kinase Activity in Blood Vessel Morphogenesis and Cell Motility-Polarity but Not Cell Proliferation

Ssang‐Taek Lim, Xiao Lei Chen, Alok Tomar et al. · Journal of Biological Chemistry · 2010 · 112 citations · Full text